- Active not recruitingPHASE3
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
This study looks into a new medicine called Setmelanotide for people aged 6 to 65 with obesity caused by specific genetic changes. Researchers want to see if this medicine helps with weight and appetite in people whose obesity is linked to faults in the MC4R pathway.
For: Obesity · Genetic ObesityUnited States · Canada · France - Active not recruitingPHASE3
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
This study looks at a new medicine called Setmelanotide for people aged 4 and over with a weight problem called hypothalamic obesity. It aims to see if the medicine helps with weight, hunger, and quality of life.
For: Hypothalamic ObesityUnited States · Canada · Germany - RecruitingPHASE3
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
This study looks at a new medicine called Setmelanotide for children and adults aged 4 and over with a certain type of obesity called hypothalamic obesity. Researchers want to see if it helps with weight, hunger, and quality of life.
For: Hypothalamic Obesity · Multiple Pituitary Hormone Deficiency Genetic Form · Septo-Optic DysplasiaUnited States · United Kingdom